Studies performed in watchful waiting cohorts suggest that patients with non-diploid or PTEN loss tumours are at higher risk of developing aggressive disease if left untreated, as these traits were associated with an increased risk of PCa-related mortality [23, 29, 30]. The gene discussed is PTEN; the disease is posterior cortical atrophy.